Showing results (11-20 of 253) with videos related to
Sort By:
Pageof 26
Diabetes Care|July 29, 2003
Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trialKasper Rossing, Peter Jacobsen, Lotte Pietraszek, et al.Diabetes Care|March 1, 2003
Smoking and progression of diabetic nephropathy in type 1 diabetesPeter Hovind, Peter Rossing, Lise Tarnow, et al.Journal of the American Society of Nephrology : JASN|July 11, 2006
Microalbuminuria as an early marker for cardiovascular diseaseDick de Zeeuw, Hans-Henrik Parving, Robert H HenningNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 15, 2007
Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patientsMaria Lajer, Lise Tarnow, Anders Jorsal, et al.Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|August 5, 2016
Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic reviewFrederik Persson, Morten Lindhardt, Peter Rossing, et al.Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|January 4, 2011
Serum uric acid as a new player in the development of diabetic nephropathyPeter Hovind, Peter Rossing, Richard J Johnson, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 14, 2003
Impact of low-dose acetylsalicylic acid on kidney function in type 2 diabetic patients with elevated urinary albumin excretion ratePeter Gaede, Henrik Post Hansen, Hans-Henrik Parving, et al.Journal of the American Society of Nephrology : JASN|March 28, 2003
Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathyPeter Jacobsen, Steen Andersen, Berit R Jensen, et al.The New England Journal of Medicine|February 8, 2008
Effect of a multifactorial intervention on mortality in type 2 diabetesPeter Gaede, Henrik Lund-Andersen, Hans-Henrik Parving, et al.Clinical Endocrinology|September 23, 2008
Microalbuminuria and obesity: impact on cardiovascular disease and mortalityKlaus Peder Klausen, Hans-Henrik Parving, Henrik Scharling, et al.Pageof 26